INSPIRNA

Inspirna is a privately-held clinical-stage biopharmaceutical company developing first-in-class drugs that target critical cancer drivers... Using a novel discovery platform, RNA-DRIVEr™, developed by Inspirna's founding scientists at Rockefeller University, and now exclusively licensed to Inspirna, we are developing first-in-class small molecule and biologic therapeutics that target cancer drivers in high unmet need oncology settings.​... To develop novel cancer medicines inspired by RNA biology. Our team of experienced drug developers is focused on generating innovative medicines that address difficult to treat cancers​.

Also known as: Inspirna, Inc.